Fused bicyclic pyrrolizinones as new scaffolds for human NK1 antagonists

A novel 5,5-fused pyrrolidine scaffold has been discovered which exhibits superior brain penetration and maintains excellent binding affinity, as well as, functional IP activity versus previously reported hNK1 antagonist.